Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Therapeutics    entities : G1 therapeutics, inc.    save search

G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| | O: 1.72% H: 4.82% C: 3.13%

first therapeutics financial results
G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-04 (Crawled : 14:30) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| | O: 1.06% H: 1.15% C: -4.4%

conference therapeutics
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-01 (Crawled : 21:00) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| | O: -1.32% H: 4.01% C: 2.45%

nasdaq grants therapeutics
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-01 (Crawled : 21:00) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

nasdaq grants therapeutics
G1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
Published: 2024-02-27 (Crawled : 13:30) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| | O: 2.61% H: 5.51% C: 1.69%

conference health care therapeutics
G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024
Published: 2024-02-15 (Crawled : 14:00) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| | O: 1.91% H: 6.42% C: 0.0%

year therapeutics financial results
G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data Monitoring Committee
Published: 2024-02-12 (Crawled : 21:00) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| | O: -44.42% H: 0.0% C: -15.66%

breast trilaciclib cancer trial therapeutics negative
G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-08 (Crawled : 12:00) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| | O: 1.37% H: 20.0% C: 16.27%

conference update therapeutics
G1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 14:00) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| | O: -1.61% H: 1.31% C: -2.94%

conference therapeutics
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-01-02 (Crawled : 22:00) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| | O: -1.61% H: 1.31% C: -2.94%

nasdaq grants therapeutics
G1 Therapeutics Presents New Post Hoc Analyses Indicating That Patients Who Previously Received Trilaciclib Have Improved Overall Survival with Subsequent Anticancer Therapy
Published: 2023-12-05 (Crawled : 14:30) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| | O: 1.0% H: 0.0% C: -8.91%

trilaciclib therapeutics therapy
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-12-01 (Crawled : 22:00) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

nasdaq grants therapeutics
G1 Therapeutics Announces Upcoming Presentation at the 2023 San Antonio Breast Cancer Symposium
Published: 2023-11-30 (Crawled : 05:00) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| | O: 1.76% H: 11.56% C: 8.67%

breast symposium presentation cancer therapeutics
G1 Therapeutics Provides Third Quarter 2023 Financial Results and Operational Highlights
Published: 2023-11-01 (Crawled : 11:00) - globenewswire.com
RVMD S | $35.81 -2.74% -2.82% 1M twitter stocktwits trandingview |
Health Technology
| | O: 0.05% H: 4.04% C: 2.73%
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| | O: -18.18% H: 5.93% C: -0.74%

therapeutics financial results
G1 Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 1, 2023
Published: 2023-10-18 (Crawled : 12:00) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| | O: 2.44% H: 6.35% C: 2.38%

business update therapeutics financial results
G1 Therapeutics Announces Upcoming Presentations at the 2023 ASCO Quality Care Symposium
Published: 2023-10-16 (Crawled : 13:00) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| | O: 0.88% H: 4.35% C: 4.35%

symposium asco care therapeutics
Black Diamond Therapeutics Announces CEO Transition
Published: 2023-09-18 (Crawled : 11:00) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| | O: 1.3% H: 0.32% C: -4.49%
BDTX A | $5.295 -7.11% -7.65% 1.9M twitter stocktwits trandingview |
Health Technology
| | O: -3.66% H: 2.63% C: 2.34%

ceo therapeutics
G1 Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-09-05 (Crawled : 15:00) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| | O: 0.59% H: 0.88% C: -0.58%

conference global therapeutics
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-09-01 (Crawled : 20:00) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

nasdaq grants therapeutics
G1 Therapeutics Provides Second Quarter 2023 Financial Results and Operational Highlights
Published: 2023-08-02 (Crawled : 11:00) - globenewswire.com
GTHX | $4.16 -2.8% -2.88% 690K twitter stocktwits trandingview |
Health Technology
| | O: 0.42% H: 0.0% C: -9.7%

therapeutics financial results
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.